Specialty Laboratories Inc.

VCs won't go near traditional diagnostics. But some are starting to bet on biomarkers that expedite drug R&D and commercialization. Only one problem: they've yet to come up with the right business mod

Sitka aims to help young companies realize their potential through offering both advice, and early-stage finance. Its latest fund focuses on continental Europe. The strong, lightweight timber of the N

Quest Diagnostics Inc. 's purchase of American Medical Laboratories Inc. (AML) for $500 million cash (including assumption of $160 million in debt) is one of a string of acquisitions made by larg

Debate about getting the FDA involved in regulating home brews has the lab and IVD industries on edge. Would agency oversight help get more FDA-cleared genetic tests on the market? by Wendy Diller It'